Crossmark

Intravenous artesunate plus oral dihydroartemisinin–piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia

Crossref DOI link: https://doi.org/10.1186/s12936-019-3085-3

Published Online: 2019-12-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sikora, Silvester Alexandro

Poespoprodjo, Jeanne Rini https://orcid.org/0000-0003-1573-734X
Kenangalem, Enny

Lampah, Daniel A.

Sugiarto, Paulus

Laksono, Ida Safitri

Ahmad, Riris Andono

Murhandarwati, E. Elsa Herdiana
Funding

Funding for this research was provided by:

Wellcome Trust (099875)

Department of Foreign Affairs and Trade, Australian Government (1037304)

National Health and Medical Research Council (1134989)

Centre for Tropical Medicine Universitas Gadjah Mada

PT Freeport Indonesia
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-30
More Information

Article History

Received: 18 September 2019

Accepted: 21 December 2019

First Online: 30 December 2019

Ethics approval and consent to participate

: This study used deidentified, secondary electronic data from the hospital’s routine surveillance system. Individual consent was not obtained. The study was approved by the Medical and Health Research Ethics Committee (MHREC) Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia (KE/FK/1228/EC/2018).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below